Allarity Therapeutics, Inc. (ALLR) vs Seres Therapeutics, Inc. (MCRB)

Allarity Therapeutics, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Allarity Therapeutics, Inc. and Seres Therapeutics, Inc. are of similar size ($14.5M and $14.4M). Allarity Therapeutics, Inc. has the higher net margin (0.00% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 13 metrics below, Allarity Therapeutics, Inc. leads on 10 and Seres Therapeutics, Inc. on 3.

Valuation

Metric ALLR MCRB Biotechnology median
P/E n/m n/m 11.36
P/S n/m 6.67 9.12
P/B n/m 0.66 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA 0.56 n/m 0.62
EV/Sales n/m 46.65 8.56
Earnings yield (102.08%) (352.22%) (34.18%)
Free cash flow yield (88.54%) (449.41%) (23.62%)

Profitability

Metric ALLR MCRB Biotechnology median
Gross margin 0.00% 100.00% 67.24%
Operating margin 0.00% (3,656.89%) 0.00%
Net margin 0.00% (2,209.55%) 0.00%
Free cash flow margin 0.00% (2,997.74%) 0.00%
Return on equity 0.00% (144.35%) (50.28%)
Return on assets 0.00% (44.85%) (45.89%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric ALLR MCRB Biotechnology median
Revenue growth (TTM) — (98.33%) 6.96%
EPS growth (last fiscal year) 95.02% 0.00% 29.86%
Revenue growth, 5-year CAGR — (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLR MCRB Biotechnology median
Debt to equity (0.63) 0.00 0.00
Current ratio 0.91 1.65 4.72
Net debt to EBITDA 1.05 0.51 1.01

Dividend

Metric ALLR MCRB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ALLR MCRB Biotechnology median
Market cap 14.54m 14.37m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack